Tracers / [11C]CP31398
[11C]CP31398
Also written as [11C]CP31398; [C-11]CP31398
- Radionuclide
- C-11 t½ 20.36 min
- Modality
- PET
- Production route
- —
- Stage
- preclinical study
- Syntheses indexed
- 1
What it is
- Compound class
- —
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| TRACERlab FX C Pro GE HealthCare | — | HPLC | 40 ± 13 yes | >99% | phenol precursor 2 | 41696278 2026 ACS Omega the whole radiochemical process was automated using the TRACERlab FX C Pro module and the optimized conditions — afforded ready-to-inject [11C]CP31398 (0.6–1.6 GBq) in 40 ± 13% (n = 6) RCY within 40 min (nondecay corrected activity yield of 10 ± 3%) |
Need this precursor?We can point you to suppliers for [11C]CP31398, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [11C]CP31398.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with C-11. Stage set/updated at stage 23 from PMID 41696278: 'Binding experiments performed with [18F]FG-CP31398 on HEK-293T cells transfected with a green fluorescent protein-p53 wild-type plasmid'.